Skip to main content
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1987 Apr 1;165(4):941–948. doi: 10.1084/jem.165.4.941

Recombinant human granulocyte colony-stimulating factor. Effects on hematopoiesis in normal and cyclophosphamide-treated primates

PMCID: PMC2188574  PMID: 3494094

Abstract

We examined the in vivo effects of recombinant human granulocyte colony- stimulating factor (rhG-CSF) in primates (cynomolgus monkeys) treated with subcutaneous doses of rhG-CSF for 14-28 d. A dose-dependent increase in the peripheral white blood cells (WBC) was seen, reaching a plateau after 1 wk of rhG-CSF treatment. The elevation of WBC was due to an increase in the absolute neutrophil count. These results demonstrate that rhG-CSF is a potent granulopoietic growth and differentiation factor in vivo. In cyclophosphamide (CY)-induced myelosuppression, rhG-CSF was able to shorten the time period of WBC recovery in two treated monkeys to 1 wk, as compared to more than 4 wk for the control monkey. Its ability to significantly shorten the period of chemotherapy-induced bone marrow hypoplasia may allow clinicians to increase the frequency or dosage of chemotherapeutic agents. In addition, the increase in absolute numbers of functionally active neutrophils may have a profound effect in the rate and severity of neutropenia-related sepsis. Furthermore, the activities reported here indicate a potential role for rhG-CSF in the treatment of patients with myelodysplastic syndrome, congenital agranulocytosis, radiation-induced myelosuppression, and bone marrow transplantation.

Full Text

The Full Text of this article is available as a PDF (569.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BOYDEN S. The chemotactic effect of mixtures of antibody and antigen on polymorphonuclear leucocytes. J Exp Med. 1962 Mar 1;115:453–466. doi: 10.1084/jem.115.3.453. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Gifford R. H., Malawista S. E. A simple rapid micromethod for detecting chronic granulomatous disease of childhood. J Lab Clin Med. 1970 Mar;75(3):511–519. [PubMed] [Google Scholar]
  3. Platzer E., Oez S., Welte K., Sendler A., Gabrilove J. L., Mertelsmann R., Moore M. A., Kalden J. R. Human pluripotent hemopoietic colony stimulating factor: activities on human and murine cells. Immunobiology. 1986 Sep;172(3-5):185–193. doi: 10.1016/S0171-2985(86)80098-5. [DOI] [PubMed] [Google Scholar]
  4. Platzer E., Welte K., Gabrilove J. L., Lu L., Harris P., Mertelsmann R., Moore M. A. Biological activities of a human pluripotent hemopoietic colony stimulating factor on normal and leukemic cells. J Exp Med. 1985 Dec 1;162(6):1788–1801. doi: 10.1084/jem.162.6.1788. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Thomas E. L., Grisham M. B., Jefferson M. M. Myeloperoxidase-dependent effect of amines on functions of isolated neutrophils. J Clin Invest. 1983 Aug;72(2):441–454. doi: 10.1172/JCI110992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Welte K., Platzer E., Lu L., Gabrilove J. L., Levi E., Mertelsmann R., Moore M. A. Purification and biochemical characterization of human pluripotent hematopoietic colony-stimulating factor. Proc Natl Acad Sci U S A. 1985 Mar;82(5):1526–1530. doi: 10.1073/pnas.82.5.1526. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Zsebo K. M., Cohen A. M., Murdock D. C., Boone T. C., Inoue H., Chazin V. R., Hines D., Souza L. M. Recombinant human granulocyte colony stimulating factor: molecular and biological characterization. Immunobiology. 1986 Sep;172(3-5):175–184. doi: 10.1016/S0171-2985(86)80097-3. [DOI] [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES